Shire Pharmaceuticals LLC will pay $56 million to settle allegations that its marketing and promotion of several drugs violated the False Claims Act, the Justice Department said Wednesday.
Search Results for: label/Westinghouse – Page 3
Jessica Tillipman and I co-teach the George Washington University Law School anti-corruption seminar in which the D.C. Metro enforcement action she wrote about will likely be a case study. I thought I would weigh in to offer some additional background information.
Tantalum, courtesy of Enough Project via YouTubeThe federal appeals court for the D.C. circuit issued its opinion Monday in National Association of Manufacturers (NAM), et al., v. Securities and Exchange Commission that partially struck down the SEC’s conflict minerals disclosure rule.
For a variety of reasons, requiring training of agents and other third-party business representatives is among the most challenging aspects of having an anti-corruption compliance program. And, it is a challenge that apparently many companies have yet to address.
Law firm Hughes Hubbard & Reed, a sponsor of the FCPA Blog, has released its FCPA/Anti-Bribery Mid-Year Alert 2010. The authors say it’s both a quick desk reference and — at 241 pages — an authoritative collection of FCPA resources. They’re right. There’s exhaustive enforcement-related information — DOJ and SEC actions, DOJ opinion procedure releases, […]
Health care giant Johnson & Johnson will pay more than $2.2 billion to resolve criminal and civil claims arising from allegations of kickbacks to U.S. doctors and improper marketing claims about three of its prescription drugs.